Navigation Links
Pharmaceutical Industry Service Company Awarded The UK's Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
Date:4/20/2012

LONDON, April 21, 2012 /PRNewswire/ --

Medaxial, the healthcare value communication specialist, today announces that it has won a Queen's Award for Enterprise in recognition of its international trade achievements.

The Queen's Awards for Enterprise are the UK's most prestigious business accolade, bestowed by Her Majesty Queen Elizabeth II on a select number of companies who have achieved outstanding results in international trade, innovation or sustainable development.  The awards are announced each year on April 21, The Queen's birthday.

Medaxial provides value communication solutions to many of the best-known names in the pharmaceutical, medical devices and diagnostics industries, and has been particularly successful in developing a client base in Europe and the USA.  The company's portfolio of services includes landscape and competitor assessment, clinical trial optimisation advice, pricing research, revenue forecasting, value message development and testing, strategic market access consultancy, health economic modelling, value dossier development, value communication toolkits and a wide range of tactical sales tools.  

Reacting to the news, one of the founding directors of Medaxial, John Fanshawe, said, "We have always believed that Medaxial's unique value communication perspective helps our clients to prosper in what are very difficult market conditions.  With continued pressure on healthcare budgets and the ever-increasing cost of bringing products to market, most pharmaceutical, biotechnology and medical devices companies now recognise the critical importance of successfully communicating the value of their products to the stakeholders who are expected to pay for them.  We have remained faithful to our belief in the central importance of value communication, and have built a reputation within the global healthcare industry for combining a rigorous approach to science and health economics with world-class
'/>"/>

SOURCE Medaxial
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... According to a new market research report ... Standing, Bariatric ), Material (Nylon, Padded, Canvas), Usage Type (Disposable, Reusable), ... MarketsandMarkets, the Medical Lifting Sling Market is poised to reach USD ... a CAGR of 11.4 % from 2015 to 2020. ... data T ables and 65 F ...
(Date:8/27/2015)... , Aug. 27, 2015  Now that Intuitive Surgical, ... Vinci S™ surgical robot, hospitals with robotic surgery programs ... also need to see where they stand with robotic ... right patients? Have they adopted best practices for safety? ... in the future? ECRI Institute, which has ...
(Date:8/27/2015)... 27, 2015   Proxsys Rx, the ... is expanding its population health management services ... of care program for hospitals and health ... hospitals with technology systems and pharmacy support ... have been mandated by Center for Medicare ...
Breaking Medicine Technology:Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 2ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 3Rx Care Management by Proxsys Rx - Transition of Care Technology Helps Prevent Hospital Medication Errors 2
... YORK and BOSTON, April 16, 2012 Duane Morris ... and Laura Vogel will present at ... from April 23–25, 2012, in New York City. These three ... across the country focused on the complexities of bringing ...
... 2012  Biodel Inc. (Nasdaq: BIOD ) today ... trial of its product candidates, BIOD-123 and BIOD-125 -- ... , BIOD-123 and BIOD-125 achieved the Company,s ... 1 clinical trial; BIOD-123 favored as lead product candidate ...
Cached Medicine Technology:Duane Morris Litigators Vincent Capuano, Anthony Fitzpatrick and Laura Vogel to Speak at American Conference Institute's Conference on Generic Pharmaceuticals 2Duane Morris Litigators Vincent Capuano, Anthony Fitzpatrick and Laura Vogel to Speak at American Conference Institute's Conference on Generic Pharmaceuticals 3Duane Morris Litigators Vincent Capuano, Anthony Fitzpatrick and Laura Vogel to Speak at American Conference Institute's Conference on Generic Pharmaceuticals 4Biodel Reports Positive Top-Line Results from Study of Experimental Ultra-Rapid-Acting Insulin Formulations 2Biodel Reports Positive Top-Line Results from Study of Experimental Ultra-Rapid-Acting Insulin Formulations 3Biodel Reports Positive Top-Line Results from Study of Experimental Ultra-Rapid-Acting Insulin Formulations 4Biodel Reports Positive Top-Line Results from Study of Experimental Ultra-Rapid-Acting Insulin Formulations 5Biodel Reports Positive Top-Line Results from Study of Experimental Ultra-Rapid-Acting Insulin Formulations 6
(Date:8/28/2015)... ... August 28, 2015 , ... Yisrayl Hawkins, Pastor and ... and pleads for swift actions to be taken in order to ease the ... , Yisrayl says scientists have yet to understand fully the real cause of global ...
(Date:8/28/2015)... ... 2015 , ... Inc. magazine today ranked PREVENT Life Safety No. ... fastest-growing private companies. The list was unveiled online at Inc.com and is the most ... three years, PREVENT ranks higher on the list than any other company in their ...
(Date:8/28/2015)... ... 2015 , ... An independent study recently conducted confirms that ... change to treatment recommendations and diagnosis. The 2015 return on investment (ROI) study ... analyzed WorldCare’s second opinion process. , The study reviewed cases across three representative ...
(Date:8/28/2015)... ... , ... Santa Rosa was recently recognized, for the fourth consecutive year, as ... KLAS “2015 Midterm Performance Review: Software & Services”, Santa Rosa achieved the highest rating ... and KLAS are directly related to our company culture.” said Richard Helppie, chairman and ...
(Date:8/28/2015)... D.C. (PRWEB) , ... August 28, 2015 , ... On October 3, 2015, BethAnn Telford ... the North Rim of the Grand Canyon with a shared mission: to beat brain cancer. ... the canyon floor, across the canyon, then up to the South Rim over 21.1 miles ...
Breaking Medicine News(10 mins):Health News:Wake Up and Smell the Sick Atmosphere Says Yisrayl Hawkins in New Article This Week 2Health News:PREVENT Life Safety Ranks No. 3660 on the 2015 Inc. 5000 With Three-Year Sales Growth of 85% 2Health News:WorldCare International, Inc. Celebrates Findings of Independent ROI Study 2Health News:Santa Rosa Consulting Recognized by Modern Healthcare as One of the Top 100 Best Places to Work and from KLAS Research with the Highest Rating for Go-Live Support 2Health News:Women Athletes Cross the Grand Canyon to Raise Funds for Brain Cancer Research – October 3rd 2
... identified two chemicals that convince cells to ignore premature signals ... 28 edition of the Journal of Experimental Medicine , ... such as cancer and muscular dystrophy, that are sparked by ... occur in the middle rather than the end of a ...
... Fla. The largest single-institution study of its kind ... with radiotherapy after surgery to remove the prostate. Men ... (PSA) test following surgery indicated their cancer had recurred. ... Clinic,s campuses in Florida and Minnesota suggest that patients ...
... Epigenetics of Common Human Disease has been chosen as ... Institutes of Health (NIH) grant for Centers of Excellence ... $16.8 million over five years. "We,re grateful ... understanding how epigenetic control affects disease," says the center,s ...
... pills raise risk higher, research finds , MONDAY, Sept. ... certain form of the autoimmune condition called antiphospholipid syndrome ... stroke, and that risk is even higher when these ... shows. , Antiphospholipid syndrome occurs when autoantibodies attach to ...
... study finds , MONDAY, Sept. 28 (HealthDay News) -- ... that are harmless in most cases but could indicate ... study suggests. , Researchers examined 320 people who were ... 7.5 percent developed skin lesions as a result of ...
... say , , MONDAY, Sept. 28 (HealthDay News) -- ... increased risk of developing atrial fibrillation, a potentially life-threatening ... of atrial fibrillation was 3.6 percent among people with ... the metabolic condition was only 2.5 percent, according to ...
Cached Medicine News:Health News:UCLA study identifies 2 chemicals that could lead to new drugs for genetic disorders 2Health News:Mayo researchers find few side effects from radiation treatment given after prostate cancer surgery 2Health News:Mayo researchers find few side effects from radiation treatment given after prostate cancer surgery 3Health News:Autoimmune Disorder Linked to Stroke, Heart Attack in Women 2Health News:Irregular Heartbeat Risk Higher in Women With Type 2 Diabetes 2Health News:Irregular Heartbeat Risk Higher in Women With Type 2 Diabetes 3
ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.15% is medication in the form of an eye drop that is used to lower the pressure inside your eye(s), also referred to as intraocular pressu...
Digital Ambulatory ECG Recorder...
Basic-level interpretive resting ECG...
Store and manage many ECG data from ECG-9020, ECG-9130 or ECG-9320 on the PC. You can search, view, compare, print, and edit analysis results of ECG, and send it to other physicians by e- mail....
Medicine Products: